U.S. Experts Still Unsure of Allergy Relief by Mouth
TOOLBOX   Resize
 Save/Share +
COMMENT
 Discussion Policy
 CLOSE
Comments that include profanity or personal attacks or other inappropriate comments or material will be removed from the site. Additionally, entries that are unsigned or contain "signatures" by someone other than the actual author will be removed. Finally, we will take steps to block users who violate any of our posting standards, terms of use or privacy policies or any other policies governing this site. Please review the full rules governing commentaries and discussions. You are fully responsible for the content that you post.
|
THURSDAY, Nov. 6 (HealthDay News) -- Even though orally delivered "sublingual immunotherapy" (SLIT) is used to treat allergies in a number of countries, there are unanswered questions about its effectiveness, appropriate use, dosage and safety of administration, according to experts at the annual meeting of the American College of Allergy, Asthma & Immunology (ACAAI), in Seattle.
SLIT -- a therapy considered investigational in the United States -- involves absorption of allergens into the body through the membranes of the mouth. Like traditional allergy injections, this is designed to help the body fight specific allergens.
"The main advantage of SLIT over traditional immunotherapy is patient convenience, since it is not an injection but oral drops or tablets that can be administered at home, and it appears to be safer than conventional immunotherapy," Dr. Ira Finegold, clinical professor of medicine at Columbia University and chairman of the R.A. Cook Institute of Allergy, St. Luke's-Roosevelt Hospital in New York, said in an ACAAI news release.
"Sublingual immunotherapy has gained wide acceptance in the treatment of allergic disease throughout Europe and South America, but the research studies in the United States have yet to show results that will convince the FDA to approve a product," Finegold said.
"We do not know the optimal dose for U.S. licensed allergen extracts for SLIT," added Dr. Linda Cox, assistant clinical professor of medicine at Nova Southeastern University College of Osteopathic Medicine in Fort Lauderdale, Fla. "There is no consistent relationship between allergen dose and clinical efficacy. Each formulation including U.S. licensed extracts will need to demonstrate its effective dosing regimen."
She noted that since "SLIT treatment is administered at home with no direct medical supervision, the physician will need to provide specific instructions to patients on how to manage adverse reactions, unplanned treatment interruptions, situations in which the dose should be withheld, and dosing adjustments for any or all of these variables."
More information
The American Academy of Family Physicians has more about allergies.
SOURCE: American College of Allergy, Asthma & Immunology, news release, Nov. 6, 2008
